Literature DB >> 2538397

Inhibition of human neutrophil NADPH oxidase by Chlamydia serovars E, K, and L2.

A I Tauber1, N Pavlotsky, J S Lin, P A Rice.   

Abstract

The effects of Chlamydia trachomatis (serovars E, K, and L2) on human neutrophil activation were examined with respect to the organisms both as primary agonists and as agents that modulate cell responses to a second stimulus. Unopsonized chlamydiae alone, at ratios of 1.5 to 100 organisms per cell, failed to elicit changes in intracellular calcium or membrane depolarization or to stimulate the respiratory burst or degranulation during 60 min of incubation. Each of these functions except the respiratory burst was also normally activated when chlamydia-infected neutrophils were subsequently stimulated with formylmethionyl leucine phenylalanine or phorbol myristate acetate; the respiratory burst was inhibited 30 to 65%. Inhibition was dependent on live organisms and was maximal within 5 min of incubation. The organisms had no effect on the superoxide (O2-) assay, and the site of chlamydial inhibition was determined at the level of the NADPH oxidase itself, not at an intermediate step in the activation cascade. The mechanism of enzyme inactivation could not be determined. These results show that unopsonized chlamydiae do not elicit responses from infected neutrophils and suggest that microbicidal mechanisms other than those dependent on elaboration of toxic oxygen-derived species are required to inactivate chlamydiae.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2538397      PMCID: PMC313237          DOI: 10.1128/iai.57.4.1108-1112.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

Review 1.  Chlamydiae.

Authors:  J Schachter; H D Caldwell
Journal:  Annu Rev Microbiol       Date:  1980       Impact factor: 15.500

2.  Fluoride-mediated activation of the respiratory burst in human neutrophils. A reversible process.

Authors:  J T Curnutte; B M Babior; M L Karnovsky
Journal:  J Clin Invest       Date:  1979-04       Impact factor: 14.808

3.  The origin of the chemiluminescence of phagocytosing granulocytes.

Authors:  B D Cheson; R L Christensen; R Sperling; B E Kohler; B M Babior
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

4.  Interaction between human polymorphonuclear leucocytes and Chlamydia trachomatis elementary bodies: electron microscopy and chemiluminescent response.

Authors:  M Zvillich; I Sarov
Journal:  J Gen Microbiol       Date:  1985-10

5.  Subcellular localization of the human neutrophil NADPH oxidase. b-Cytochrome and associated flavoprotein.

Authors:  N Borregaard; A I Tauber
Journal:  J Biol Chem       Date:  1984-01-10       Impact factor: 5.157

6.  Inhibition of neutrophil lysosome-phagosome fusion associated with influenza virus infection in vitro. Role in depressed bactericidal activity.

Authors:  J S Abramson; J C Lewis; D S Lyles; K A Heller; E L Mills; D A Bass
Journal:  J Clin Invest       Date:  1982-06       Impact factor: 14.808

7.  Biochemical requirements for singlet oxygen production by purified human myeloperoxidase.

Authors:  J R Kanofsky; J Wright; G E Miles-Richardson; A I Tauber
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

8.  Chlamydia trachomatis (L2 serovar) binds to distinct subpopulations of human peripheral blood leukocytes.

Authors:  J Bard; D Levitt
Journal:  Clin Immunol Immunopathol       Date:  1986-02

9.  Inhibition of phagolysosome fusion is localized to Chlamydia psittaci-laden vacuoles.

Authors:  L G Eissenberg; P B Wyrick
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

10.  Interaction between Chlamydia spp. and human polymorphonuclear leukocytes in vitro.

Authors:  K B Register; P A Morgan; P B Wyrick
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.441

View more
  11 in total

Review 1.  Interaction of chlamydiae and host cells in vitro.

Authors:  J W Moulder
Journal:  Microbiol Rev       Date:  1991-03

2.  Early complement components enhance neutralization of Chlamydia trachomatis infectivity by human sera.

Authors:  J S Lin; L L Yan; Y Ho; P A Rice
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

3.  Leishmania pifanoi amastigotes avoid macrophage production of superoxide by inducing heme degradation.

Authors:  Nam-Kha Pham; Jennifer Mouriz; Peter E Kima
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

4.  Futile cycling increases sensitivity toward oxidative stress in Escherichia coli.

Authors:  Kristin J Adolfsen; Mark P Brynildsen
Journal:  Metab Eng       Date:  2015-02-27       Impact factor: 9.783

5.  Human granulocytic ehrlichiosis agent inhibits superoxide anion generation by human neutrophils.

Authors:  J Mott; Y Rikihisa
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

6.  The inflammatory cytokine response to Chlamydia trachomatis infection is endotoxin mediated.

Authors:  R R Ingalls; P A Rice; N Qureshi; K Takayama; J S Lin; D T Golenbock
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

7.  Roles of Ca2+ and F-actin in intracellular aggregation of Chlamydia trachomatis in eucaryotic cells.

Authors:  M Majeed; M Gustafsson; E Kihlström; O Stendahl
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

8.  Production of reactive oxygen species is turned on and rapidly shut down in epithelial cells infected with Chlamydia trachomatis.

Authors:  Gaëlle Boncompain; Benoît Schneider; Cédric Delevoye; Odile Kellermann; Alice Dautry-Varsat; Agathe Subtil
Journal:  Infect Immun       Date:  2009-10-26       Impact factor: 3.441

9.  Selective translocation of annexins during intracellular redistribution of Chlamydia trachomatis in HeLa and McCoy cells.

Authors:  M Majeed; J D Ernst; K E Magnusson; E Kihlström; O Stendahl
Journal:  Infect Immun       Date:  1994-01       Impact factor: 3.441

10.  A Kinetic Platform to Determine the Fate of Hydrogen Peroxide in Escherichia coli.

Authors:  Kristin J Adolfsen; Mark P Brynildsen
Journal:  PLoS Comput Biol       Date:  2015-11-06       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.